Pyoderma gangrenosum
| Pyoderma gangrenosum | |
|---|---|
| Classification and external resources | |
 Pyoderma gangrenosum on the leg of a patient with Crohn's disease. |
|
| ICD-10 | L88 |
| ICD-9 | 686.01 |
| eMedicine | article/1123821 |
| MeSH | D017511 |
Pyoderma gangrenosum is a disease that causes tissue to become necrotic, causing deep ulcers that usually occur on the legs. When they occur, they can lead to chronic wounds. Ulcers usually initially look like small bug bites or papules, and they progress to larger ulcers. Though the wounds rarely lead to death, they can cause pain and scarring.
The disease was identified in 1930. It affects approximately 1 person in 100,000 in the population. Though it can affect people of any age, it mostly affects people in their 40s and 50s.[1]
Contents |
[edit] Types
There are two main types of pyoderma gangrenosum:[1]
- the 'typical' ulcerative form, which occurs in the legs
- an 'atypical' form that is more superficial and occurs in the hands and other parts of the body
Other variations are[2]:
- Peristomal pyoderma gangrenosum is 15% of all cases of pyoderma
- Bullous pyoderma gangrenosum
- Pustular pyoderma gangrenosum[3]
- Vegetative pyoderma gangrenosum[4]
[edit] Causes
Though the etiology is not well understood, the disease is thought to be due to immune system dysfunction, and particularly improper functioning of neutrophils. At least half of all pyoderma gangrenosum patients also suffer from illnesses that affect their systemic function.[1] For instance, ulcerative colitis, rheumatoid arthritis, and multiple myeloma (MM) sufferers have the condition. It can also be part of a syndrome, for instance in PAPA syndrome. Major and minor trauma are also believed to play a role. [5]
[edit] Associations
The common conditions associated with pyoderma gangrenosum are:
- Inflammatory bowel disease:
- Arthritides:
- Haematological disease:
[edit] Treatment
First-line therapy for disseminated or localized instances of pyoderma gangrenosum is systemic treatment by corticosteroids and cyclosporine. If ineffective, alternative therapeutic procedures include systemic treatment with corticosteroids and mycophenolate mofetil; mycophenolate mofetil and cyclosporine; tacrolimus; thalidomide; infliximab; or plasmapheresis.[7]
[edit] See also
[edit] References
- ^ a b c Jackson JM and Callen JP. 2006. Emedicine: Pyoderma Gangrenosum. Retrieved on January 23, 2007.
- ^ Brooklyn T, Dunnill G, Probert C (2006). "Diagnosis and treatment of pyoderma gangrenosum". BMJ 333 (7560): 181–4. doi:10.1136/bmj.333.7560.181. PMC 1513476. PMID 16858047. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1513476.
- ^ Shankar S, Sterling JC, Rytina E (2003). "Pustular pyoderma gangrenosum". Clin. Exp. Dermatol. 28 (6): 600–3. doi:10.1046/j.1365-2230.2003.01418.x. PMID 14616824.
- ^ Langan SM, Powell FC (2005). "Vegetative pyoderma gangrenosum: a report of two new cases and a review of the literature". Int. J. Dermatol. 44 (8): 623–9. doi:10.1111/j.1365-4632.2005.02591.x. PMID 16101860.
- ^ Seat belt pyoderma gangrenosum: minor pressure as a causative factor. Rashid RM. J Eur Acad Dermatol Venereol. 2008 Nov;22(10):1273-4.
- ^ Maintenance on GPnotebook site
- ^ Reichrath J, Bens G, Bonowitz A, Tilgen W (2005). "Treatment recommendations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients". J. Am. Acad. Dermatol. 53 (2): 273–83. doi:10.1016/j.jaad.2004.10.006. PMID 16021123.
[edit] External links
|
|||||||||||||||||||||||
|
||||||||||||||||||||||
 |
This cutaneous condition article is a stub. You can help Wikipedia by expanding it. |
 |
This disease article is a stub. You can help Wikipedia by expanding it. |
